ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

Print Page
Email Article

Abstract: Immunophenotyping Predictive of Mycoplasma Infection in Patients with Chronic Fatigue Syndrome?

  [ 38 votes ]   [ Discuss This Article ] • October 1, 2003

Journal: J of Chronic Fatigue Syndrome, Vol. 11(2) 2003, pp. 51-69  Authors: Jo Nijs, MSc; Danny Coomans, PhD; Garth L. Nicolson, PhD; Pascale De Becker, PhD; Demanet Christian, MD, PhD; Kenny De Meirleir, MD, PhD
Jo Nijs and Pascale De Becker are affiliated with the Department of Human Physiology, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel (VUB), Belgium.
Danny Coomans is affiliated with the School of Mathematical and Physical Sciences, James Cook University, Australia.
Garth L. Nicolson is affiliated with the Institute for Molecular Medicine, Huntington Beach, CA, USA.
Demanet Christian is affiliated with the Division of Hematology and Immunology, Academic Hospital Vrije Universiteit Brussel, Belgium.
Kenny De Meirleir is affiliated with the Department of Human Physiology, Faculty of Physical Education and Physiotherapy, and the Chronic Fatigue Clinic, Vrije Universiteit Brussel (VUB), Belgium.
Address correspondence to: Jo Nijs, Vakgroep MFYS/Sportgeneeskunde, AZ-VUB KRO-gebouw-l, Laarbeeklaan 101, 1090 Brussel, Belgium (E-mail:

ABSTRACT. An impaired immune system and opportunistic infections are considered important characteristics in the pathophysiology of Chronic Fatigue Syndrome (CFS). Using immunofluorescence we examined healthy subjects (N = 35) and two subsets of CFS patients: those without evidence of Mycoplasma (N = 55) and those with evidence of a Mycoplasma infection in their blood (N = 131). Using monoclonal antibodies and forensic polymerase chain reaction for detection of M. hominis, M. fermentans, M. pneumoniae and M. penetrans, we examined leukocytes in peripheral blood samples.

Both patient groups presented with significantly elevated CD25+ (activated) cells as compared to healthy volunteers. CFS patients without evidence of mycoplasma infection(s) had increased amounts of CD5+ B-cells. Stepwise discriminant analysis indicated the number of activated cells, number of memory CD4+ cells and percentage of suppressor T-cells (lower in Mycoplasma+ patients as compared to Mycoplasma- patients) as the discriminant variables. A classification tree, for predicting the presence of Mycoplasma species in CFS patients, was constructed. Taken together, these data confirm earlier reports on immune activation among CFS patients, but this does not appear to be specific for Mycoplasma-infected CFS patients.

KEYWORDS. Chronic fatigue syndrome, Mycoplasma, immunity, immunofluorescence


Chronic Fatigue Syndrome (CFS), or alternatively Chronic Fatigue Immune Dysfunction Syndrome, is a chronic debilitating disease of unknown cause (1). In such patients Mycoplasma species infections may serve as primary or secondary etiological factors. Mycoplasma are prokaryotes containing circular DNA and some ribosomes (2), lacking a cell wall and certain cellular organelles. The high prevalence of Mycoplasma species infections in CFS has been discussed at length in the scientific literature (3-8).

The presence of opportunistic infections in CFS suggests an impaired immune system in these patients. Indeed, a deregulated 2'5' oligoadenylate synthetase ribonuclease antiviral pathway (9-11) and a reduced natural killer cell function (13-15) are two characteristics of impaired immunity in at least subsets of CFS patients. Although some Mycoplasma species are part of the normal human flora, others are capable of causing complex systemic infections in immunocompromised hosts, as seen in HIV-AIDS (16) and CFS (3-7).

The immunological properties of Mycoplasma species have been studied extensively. M. fermentans has been shown to affect the immune system via T - or B-cell activation and macrophage stimulation [reviewed in (2)]. A membrane-associated complement C3-activating protein (M161Ag), from M. fermentans, efficiently promotes the production of nitric oxide (NO), interleukin I beta (IL-1 beta), tumour necrosis factor alpha (TNF-alpha), IL-10 and IL-6 in human peripheral blood monocytes (2,17-19). Activation of the complement system by C3 in M.fermentans-infected cells in turn stimulates the release of C5a chemotactic factor and enhances phagocytic activity. Kikkawa et al. (17) have demonstrated that the human complement system was able to clear M. fermentans from the surface of infected human cells, but was not able to prevent persisting low-grade infections in human tumour cell lines, probably due to rapid invasion of the infected cells into tissues.

There are some data available that describe host defence action against respiratory mycoplasmosis caused by M. pneumoniae and M. pulmonis. Both innate (mediated by alveolar macrophages) and humoral immunity appear to be of prime importance in the defence action against these Mycoplasma infections (20). Moreover, T-cell responses in respiratory Mycoplasma infections can result in exacerbation of lung lesions, whereas innate immunity is crucial in defence of the lungs and humoral immunity in preventing dissemination of infection to extrapulmonary sites (20). In accordance with these observations, a recent report provides an explanation for the characteristic chronic nature of Mycoplasma spp. infections.

In this report M. pulmonis infection induced a transitional shift of the TH-I (T helper cells type 1)- TH-2 balance in favour of humoral immunity, which is thought to allow the microorganism to survive (21). The exact role of cell-mediated immunity in Mycoplasma infections, however, remains to be established.

To our knowledge, the possible effects of Mycoplasma species on immune cells in CFS patients have not been examined. Therefore, we examined CFS patients with or without Mycoplasma infection(s) and healthy volunteers to see if certain immune patterns were characteristic of chronic infections in these patients.

© 2003 by The Haworth Press, Inc. All rights reserved. (Received via Co-Cure.)

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Vitamin D3 Extreme™ Optimized Curcumin Longvida®

Article Comments

Be the first to comment on this article!

Post a Comment

NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map